Funds holding ESTRELLA IMMUNOPHARMA INC
ISIN US2975841048 · United States
- Fund holders
- 8
- Of which ETFs
- 1 7 other funds
- Value held
- 645.8K $
- Share of capital
- 1.4 % of 43.5M shares on Aug 11, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 268,605 | 279.3K $ | 0.62 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 148,247 | 154.2K $ | 0.00 % | 0.34 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 99,247 | 108.2K $ | 0.00 % | 0.23 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 49,660 | 51.6K $ | 0.00 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 27,548 | 30K $ | 0.06 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 16,762 | 18.3K $ | 0.04 % | as of May 31, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 2,373 | 2.5K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 1,582 | 1.7K $ | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 8 | 0 | 614,024 | +19.0 % |
| 2026Q2 | 8 | 0 | 516,141 | +3.7 % |
| 2026Q1 | 8 | 0 | 497,722 | +0.3 % |
| 2025Q4 | 8 | 0 | 496,186 | +25.0 % |
| 2025Q3 | 8 | 0 | 397,089 | +2.1 % |
| 2025Q2 | 8 | 0 | 388,858 | +187.9 % |
| 2025Q1 | 8 | +1 | 135,066 | +19.8 % |
| 2024Q4 | 7 | +3 | 112,778 | +84.3 % |
| 2024Q3 | 4 | 0 | 61,179 | -0.7 % |
| 2024Q2 | 4 | +3 | 61,634 | +3,796.0 % |
| 2024Q1 | 1 | 1,582 |
Institutional managers
14 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,099,000 | 4.3M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 264,388 | 280.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 157,485 | 166.9K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 62,795 | 66.6K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 43,252 | 45.8K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 39,890 | 42.3K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 19,624 | 20.8K $ | as of Mar 31, 2026 |
| US BANCORP \DE\ | 16,904 | 17.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 15,079 | 16K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 6,600 | 7K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 4,859 | 5.2K $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 1,089 | 1.2K $ | as of Mar 31, 2026 |
| WOLVERINE ASSET MANAGEMENT LLC | 468 | 496 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of ESTRELLA IMMUNOPHARMA INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 4.99 % | 2,051,409 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ESTRELLA IMMUNOPHARMA INC". https://titelia.com/en/stocks/estrella-immunopharma-inc-US2975841048